Biotech and Pharmaceuticals Jobs

Posted on August 31st, 2007 in Career Development by Warren

FYI. A good summary of the positions and salaries available for newly grads at a biotech/pharma.



Lab Tech
Lab techs perform the routine maintenance tasks—cleaning and maintaining
glassware, working with animal colonies, operating lab equipment, and so
on—that are needed to keep labs functioning. A high school diploma is
required, and many people with college degrees start here as well. Salary
range: $24,000 to $35,000.Research Associate

A BS or MS in some form of chemistry or biology and experience working in a
lab are typically required to land this job. Associates work at the bench,
conducting experiments under the guidance of PhD scientists. If you’re coming
out of school with some lab experience but no PhD and you want to work in
R&D, this is the job for you. Salary range: $33,000 to $65,000.

Research Scientist

After receiving a PhD and completing a postdoc, a scientist can get a job as
a research scientist (sometimes the initial title is Associate Scientist),
designing and conducting experiments and writing up results for publication
when appropriate. Salary range: $65,000 to $110,000.

Sales Rep

Sales reps work with physicians, hospitals, HMOs, and countless other medical
institutions to keep health-care professionals abreast of—and, if possible,
partial toward—their company’s line of products. Some of these jobs require
extensive travel; others don’t. A bachelor’s degree in the sciences will
help, but previous sales experience is more important in landing one of these
jobs. Big Pharma companies have huge staffs of sales reps, so these positions
can offer the necessary prerequisite for the more complex job of
biotechnology sales, where salaries are higher and bonuses can exceed base
salary. Salary range: $42,000 to $76,000, plus incentives.

Marketing Analyst/Associate Product Manager

Job seekers without a background in science can also find work on the
marketing side in Big Pharma and large biotech companies. A marketing analyst
is primarily responsible for coordinating and implementing campaigns for
specific drugs, audiences, or both. This involves a little strategy and a lot
of execution—things like developing collateral pieces, working as a liaison
to advertising agencies, and overseeing a company presence at conventions.
Many MBAs enter the industry this way, and—perhaps more important—few without
MBAs move far beyond the marketing analyst level, although this varies from
company to company. Other people come to these positions from sales. Salary
range: $38,000 to $75,000.

Product Manager

This job requires managing a team of people and working to determine price,
distribution, brand image, forecasting, and overall strategy for one or more
drugs. On a micro level, the job can be claustrophobic: Imagine spending 13
months of 6-day weeks learning every aspect of a single drug, then having the
company decide that it would be best simply to let the product die. But over
the years you should be exposed to some of the most important, dynamic, and
profitable drug markets in the industry, an experience that will give you a
big-picture understanding of the industry and make you a greater asset to the
company. Salary range: $60,000 to $100,000.

Programmer/Analyst

These titles cover a wide variety of jobs, but put simply,
programmers/analysts are computer people. There’s a lot of complex database
work to be done in this industry, particularly for clinical trials, which can
involve thousands of patients (sometimes in several countries) with elaborate
medical histories and completely different responses to each of the drugs and
placebos being tested. And the computational demands of postgenomic research
are enormous, creating demand for job seekers who have backgrounds combining
science with computers. Bachelor’s degrees are usually required (though not
always). Salary range: $47,000 to $86,000.

Regulatory Affairs Associate

The regulatory affairs career path suits job seekers who have a background in
science but don’t want to do lab work. A regulatory affairs associate
completes the piles of paperwork required by the FDA. A BS is typically
required; candidates without one may find themselves lost for several months.
Those with a law degree come in at a higher level and with greater
responsibilities, but with the same basic job description. Salary range:
$39,000 to $84,000.

Clinical Research Physician (CRP)

CRPs are MDs who develop and implement plans for ushering experimental drugs
through preapproval clinical trials. They work on cross-functional teams to
maximize understanding of the pharmacological, regulatory, and clinical
dimensions of the drugs being studied. Salary range: $90,000 to $200,000;
company-sponsored speaking tours and other promotional events offer the
enterprising physician numerous other ways to increase net income.

Source: Wetfeet

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

How to make your millions

Posted on August 30th, 2007 in Random Stuff by Warren

Start early. Invest consistently. Cheers to compound interest.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Beer pong!

Posted on August 29th, 2007 in Entrepreneurship by Gary

is now big business.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Investing opportunity?

Posted on August 29th, 2007 in Random Stuff by Gary

From this WSJ article about the woes of Countrywide Financial (CFC):

It is unclear how well borrowers will cope once the higher payments set in. These option ARMs, many granted in 2004 and 2005 at the top of the housing boom, will be “stress-tested” beginning next year, S&P’s Mr. Plesser says.

A “significant portion” of those option ARMs are covered by private mortgage insurance against losses because of defaults, the Countrywide spokesman says.

If option ARMS are protected by private mortgage insurance (insurance for those who put < 20% downpayment), PMI companies may suffer unforeseen losses next year due to policies being triggered by homeowners’ failures to pay. These payments would go to Countrywide and other lenders. It may make sense to short companies who do significant business in PMI…

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

How facebook makes money

Posted on August 27th, 2007 in Random Stuff by Warren

Multiple streams of income. More than just ads.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Cliffs notes on the current economic crisis - Structured finance & the market

Posted on August 24th, 2007 in Finance by Gary

Structured finance has been a hot area the past few years. However, it is this same area that is getting hammered right now. Thanks to foreclosures due to people getting in over their heads with jumbo, piggyback, NINJA (no income no job or assets) loans, etc. It’s not just that, but private equity firms used to demand covenant-lite loans, in which there are less restrictions to the borrower. Structured finance basically deals with the securitization of assets. Assets, or collateral, comprise of debt instruments such as bonds and mortgages (2 types of loans). The product of this securitization is a collateralized debt obligation, or CDO.

Another area being affected by the credit crunch is the commercial paper, or CP, market. Commercial paper  are short term securities issued by big business with stellar credit ratings. They can usually at secure rates better than what they could get through a bank. Although CP is supposedly safe, it was discovered that CDOs that served as their collateral had bad mortgages as the underlying asset. This froze up the CP market, which is very problematic for business because they depend on this short term financing for day-to-day operations. On top of that, many corporations have conduits - subsidiaries which are funded through commercial paper, investing that money in longer-term, higher yielding bonds. Funding a long-term loan with short-term financing is very risky; now they face issues of paying back previous CP without being able to secure new CP funding, and trying to maintain their bond positions.

The Fed’s response has been to slash the discount rate. The Fed will make loans to banks while taking on their bad MBS (mortgage-backed securities) as collateral. This is controversial. In addition, instead of just an overnight loan it is now stretched to 30 days, which is quite lenient. Don’t get the discount rate confused with the federal funds target rate which is what is referred to when the media talks about the Fed raising or lowering interest rates. The Fed, as well as the central banks of other countries (such as ECB in Europe), have been trying to flood the markets with liquidity in order to revive the market out of this cash freeze and unavailability of funds. Banks have been unwilling to lend even with each other, as the actual federal funds target rate (the rate at which banks borrow from each other) has been lower than the actual rate. It means that banks are unwilling to lend to each other at the 5.25% target rate; the actual rate is higher than that. Banks are trying to hold on to their cash.

It will be interesting to see how this shakes out. Lehman Brothers, the leader in selling bonds backed by risky mortgages (subprime loans), is laying off 4.2% of its workforce, or about 1,200 people… not good news.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Say hello to GOD.

Posted on August 23rd, 2007 in Entrepreneurship by Warren

Mark Zuckerberg, 23.

The guy that has changed the way we spend our time on the internet. Can you believe it? 23..

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Quant funds

Posted on August 22nd, 2007 in Finance by Warren

As a result of some of the disastrous hedge fund performance from the last few weeks, we’re starting to hear whispers about whether quantitative strategies are really viable or not.  If you don’t know what a quant fund is, this about sums it up:

“The models replace instinct. They try to turn historical trends into predictive science, using elegant mathematics seemingly above the comprehension of your average 401(k) participant or Wall Street fund manager.”

The kind of people these quant based hedge funds hire to develop these models:

“Instead of veteran, market-savvy traders waving fistfuls of sell slips, the elite quant funds employ Nobel nerds with math PhDs, often divorced from the real world. It’s not for nothing that they are called “black-box” funds — opaque to outsiders, the boxes contain investment magic understood by only the wizards who conjured it up.”

Must be a tough time to a be a quantitative analyst! More here.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Should we short Cramer?

Posted on August 22nd, 2007 in Random Stuff by Gary

Barron’s had a good article about the always entertaining James J. Cramer of CNBC’s Mad Money.

Jim is a very smart guy with a Harvard Law degree, a stint at Goldman Sachs, and a successful hedge fund. However, can we really make steady and consistent money by shorting Cramer’s picks?

I can’t imagine that other hedge funds aren’t doing that. Furthermore, this simple shorting strategy can probably be broadly applied to other stock recommendation shows, articles and newletters due to the trend that most stocks in the spotlight jump the next day, moving sideways or down in the following days after the intial “pop.”

On another note, Jim Cramer’s Confessions of a Street Addict looks like a good read.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]

Quarter Life Crisis, CFA, Stress

Posted on August 22nd, 2007 in Finance by Gary

I think quarter life crisis is an apt name in that at ~25 years of age (assuming you live 100 years) many people don’t know what to do with their lives. Most people have not found a job or field that they would like to be involved with. Warren, myself, and many of our friends & colleagues are in this situation. We are always on the lookout for something that piques our interest. At this age we are young enough to change careers and pick up new things quickly, yet old enough to have completed undergrad/grad education as well as some job experience.

 I’ve been studying for the CFA level 1 exam being administered this coming December. It is made up of 5 main topics:
Ethics and quantitative methods
Economics
Financial statement analysis
Corporate finance, analysis of equity investments, and portfolio management
Fixed income, derivatives, and alternative investments

I am currently on the 3rd topic, financial statement analysis, which is extremely dry and boring. The first two topics are straightforward but provides a lot to memorize. Ethics is memorization, quant methods is formula memorization and calculations (you need to learn how to use the TI - BAII Plus calculator), and economics is a mix of micro and macro. My interests lie in the 5th topic of fixed income, derivatives, and alternative investments.   

Studying and stressing has led me to thinking about the Stress Eraser product, which warren mentioned previously. It definitely looks promising. I may get it. However, a cheaper alternative is Classical Music and Slow, Deep Breaths.

[del.icio.us] [Digg] [Facebook] [Google] [MySpace] [Slashdot] [Technorati]
Next Page »